These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 42228)

  • 1. Metabolism of mesocarb in the rat.
    Polgár M; Vereczkey L; Szporny L; Czira G; Tamás J; Gács-Baitz E; Holly S
    Xenobiotica; 1979 Aug; 9(8):511-9. PubMed ID: 42228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of hydroxylated mesocarb metabolites for doping control.
    Vahermo M; Suominen T; Leinonen A; Yli-Kauhaluoma J
    Arch Pharm (Weinheim); 2009 Apr; 342(4):201-9. PubMed ID: 19340833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatography electrospray ionization tandem mass spectrometry for the detection of mesocarb abuse in horse doping.
    Appolonova SA; Baranov PA; Mesonzhnik NV; Brazhnikova DO; Rodchenkov GM
    Drug Test Anal; 2011 Oct; 3(10):717-23. PubMed ID: 21964865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, metabolism, and disposition of the antiinflammatory 3-[2-(4-methylphenyl)-thioethyl]-sydnone-5-14C in the rat.
    Pirl JN; Bell CL; Lu MC; Bauer L
    Arzneimittelforschung; 1985; 35(3):578-84. PubMed ID: 4039583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-electrospray ionization ion trap mass spectrometry for analysis of mesocarb and its metabolites in human urine.
    Appolonova SA; Shpak AV; Semenov VA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Feb; 800(1-2):281-9. PubMed ID: 14698267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dopamine uptake by a new psychostimulant mesocarb (Sydnocarb).
    Erdö SL; Kiss B; Rosdy B
    Pol J Pharmacol Pharm; 1981; 33(2):141-7. PubMed ID: 7312716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption and disposition of [14C]-molsidomine in laboratory animals.
    Fromson JM; Illing HP; Ings RM; Johnson KI; Johnson P; Ostrowski J; Schraven E; Steward A
    Arzneimittelforschung; 1981; 31(2):337-45. PubMed ID: 6894378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mesocarb analogues in urine and plasma of rats by high-performance liquid chromatography and thermospray liquid chromatography-mass spectrometry.
    Pyo H; Park SJ; Park J; Yoo JK; Yoon B
    J Chromatogr B Biomed Appl; 1996 Dec; 687(1):261-9. PubMed ID: 9001972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synocarb metabolism in rats].
    Polgár M; Vereczkey L; Czira G; Tamás J; Szporny L
    Acta Pharm Hung; 1978; 48 Suppl():23-4. PubMed ID: 749521
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat.
    Koble DL; Koons JC; Fischer LJ
    Drug Metab Dispos; 1985; 13(3):305-11. PubMed ID: 2861988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and application of a screening method for beta2-agonists, anti-estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometry.
    Kang MJ; Hwang YH; Lee W; Kim DH
    Rapid Commun Mass Spectrom; 2007; 21(2):252-64. PubMed ID: 17171780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat.
    Bolton GC; Griffiths LA
    Drug Metab Dispos; 1979; 7(6):388-92. PubMed ID: 43225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peculiarities of clinical activity and pharmacokinetics of sydnocarb (sydnocarbum), an original psychostimulant.
    Rudenko GM; Altshuler RA
    Agressologie; 1979; 20(D):265-70. PubMed ID: 45391
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic fate of [14C] quercetin in the ACI rat.
    Ueno I; Nakano N; Hirono I
    Jpn J Exp Med; 1983 Feb; 53(1):41-50. PubMed ID: 6876476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of vincamine in the rat in vivo and in vitro.
    Vereczkey L; Tamás J; Czira G; Szporny L
    Arzneimittelforschung; 1980; 30(11):1860-5. PubMed ID: 7192994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structural investigations of one of the major metabolites of "Sydnocarb" with the MS, IR, and NMR methods].
    Czira G; Polgár M; Tamás J; Holly S; Radics L; Vereczkey L
    Acta Pharm Hung; 1978; 48 Suppl():25-6. PubMed ID: 749522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.